Edition:
United Kingdom

BTG PLC (BTG.L)

BTG.L on London Stock Exchange

827.50GBp
14 Dec 2018
Change (% chg)

1.50 (+0.18%)
Prev Close
826.00
Open
824.50
Day's High
827.50
Day's Low
824.00
Volume
848,800
Avg. Vol
1,923,380
52-wk High
853.00
52-wk Low
467.40

Chart for

About

BTG plc is medical device development and healthcare service provider. It provides Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care and licensing business. It operates through three segments: Interventional Medicine, Pharmaceuticals and Licensing. The... (more)

Overall

Beta: 0.11
Market Cap(Mil.): £2,754.76
Shares Outstanding(Mil.): 386.36
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 82.78 31.13 34.39
EPS (TTM): 0.09 -- --
ROI: 3.10 15.55 14.96
ROE: 3.68 16.92 16.52

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 21 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn (US$4.22bn)bridge loan from Barclays Bank.

21 Nov 2018

Deals of the day-Mergers and acquisitions

Nov 20 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

20 Nov 2018

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 20 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn bridge loan from Barclays Bank.

20 Nov 2018

Boston Scientific builds medical technology with $4.2 billion BTG deal

LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds ($4.24 billion) in cash, adding technology to fight cancer and other serious diseases to its portfolio.

20 Nov 2018

Boston Scientific builds medical tech with $4.2 billion BTG deal

LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds in cash, adding technology to fight cancer and other serious diseases to its portfolio.

20 Nov 2018

UPDATE 2-Boston Scientific builds medical tech with $4.2 billion BTG deal

* U.S. group's biggest deal since 2006 Guidant acquisition (Adds latest shares, analyst comment, further details)

20 Nov 2018

Boston Scientific offers to buy UK's BTG for about $4.24 billion

Nov 20 U.S. medical device maker Boston Scientific Corp said it offered to buy British pharmaceutical firm BTG Plc for about 3.3 billion pounds ($4.24 billion) in cash.

20 Nov 2018

Brexit, trade progress drive European stocks up after tech rout

LONDON European shares recovered on Tuesday as hopes for an easing of the Sino-U.S. trade war and an imminent Brexit deal chased away the previous session's fears of a peak in tech stocks.

13 Nov 2018

Brexit, trade progress drive European stocks up after tech rout

LONDON European shares recovered on Tuesday as hopes for an easing of the Sino-U.S. trade war and an imminent Brexit deal chased away the previous session's fears of a peak in tech stocks.

13 Nov 2018

PRESS DIGEST- British Business - Nov 13

Nov 13 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

13 Nov 2018

Earnings vs. Estimates